Search

Your search keyword '"Kall, Meaghan"' showing total 196 results

Search Constraints

Start Over You searched for: Author "Kall, Meaghan" Remove constraint Author: "Kall, Meaghan"
196 results on '"Kall, Meaghan"'

Search Results

1. Genomic assessment of invasion dynamics of SARS-CoV-2 Omicron BA.1.

2. Estimated number of lives directly saved by COVID-19 vaccination programmes in the WHO European Region from December, 2020, to March, 2023: a retrospective surveillance study

3. Vaccine effectiveness against hospitalisation estimated using a test-negative case-control study design, and comparative odds of hospital admission and severe outcomes with COVID-19 sub-lineages BQ.1, CH.1.1. and XBB.1.5 in England

4. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study

5. Emergence of the delta variant and risk of SARS-CoV-2 infection in secondary school students and staff: Prospective surveillance in 18 schools, England

7. Antibody persistence and neutralising activity in primary school students and staff: Prospective active surveillance, June to December 2020, England

8. Emergence of SARS-CoV-2 Alpha (B.1.1.7) variant, infection rates, antibody seroconversion and seroprevalence rates in secondary school students and staff: Active prospective surveillance, December 2020 to March 2021, England

10. SARS-CoV-2 infection, antibody positivity and seroconversion rates in staff and students following full reopening of secondary schools in England: A prospective cohort study, September–December 2020

11. SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)

12. COVID‐19 Vaccine Safety in Pregnancy, A Nested Case–Control Study in Births From April 2021 to March 2022, England.

13. Epidemiology of Confirmed COVID-19 Deaths in Adults, England, March-December 2020

14. Positive Voices 2022: Methodology and recruitment of a national survey of people with HIV and accessing care in England, Wales, and Scotland (Preprint)

17. Consensus statement on the role of health systems in advancing the long-term well-being of people living with HIV

19. Lessons learned from the first European project on the integration of infectious diseases in testing services, data collection and country responses

23. Temporal changes to adult case fatality risk of COVID-19 after vaccination in England between May 2020 and February 2022: a national surveillance study.

25. Vaccine effectiveness against hospitalisation and comparative odds of hospital admission and severe outcomes with BQ.1, CH.1.1. and XBB.1.5 in England.

26. Comparison of two COVID-19 mortality measures used during the pandemic response in England.

28. Comparative transmission of SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2) variants and the impact of vaccination: national cohort study, England

29. Do Antibody Positive Healthcare Workers Have Lower SARS-CoV-2 Infection Rates than Antibody Negative Healthcare Workers? Large Multi-Centre Prospective Cohort Study (The SIREN Study), England: June to November 2020

30. COVID-19 deaths in children and young people in England, March 2020 to December 2021: An active prospective national surveillance study

32. Assessment of mortality and hospital admissions associated with confirmed infection with SARS-CoV-2 Alpha variant: a matched cohort and time-to-event analysis, England, October to December 2020

33. Parents’ and teachers’ attitudes to and experiences of the implementation of COVID-19 preventive measures in primary and secondary schools following reopening of schools in autumn 2020: a descriptive cross-sectional survey

36. Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant

37. Patient satisfaction with HIV care service in Spain: results from a cross-sectional patient survey.

39. Long-Term Health-Related Quality of Life in Non-Hospitalized Coronavirus Disease 2019 (COVID-19) Cases With Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in England: Longitudinal Analysis and Cross-Sectional Comparison With Controls

40. Comparative transmission of SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2) variants and the impact of vaccination: national cohort study, England

41. Secondary attack rates in primary and secondary school bubbles following a confirmed case: Active, prospective national surveillance, November to December 2020, England

43. COVID-19 Deaths in Children and Young People: Active Prospective National Surveillance, March 2020 to December 2021, England

44. Comparative Analysis of the Risks of Hospitalisation and Death Associated with SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2) Variants in England

46. Effectiveness of COVID-19 vaccines against the Omicron (B.1.1.529) variant of concern

47. Emergence of the Delta Variant and risk of SARS-CoV-2 infection in secondary school students and staff: prospective surveillance in 18 schools, England

48. Surge in SARS-CoV-2 transmission in school-aged children and household contacts, England, August to October 2021

49. Estimated number of deaths directly averted in people 60 years and older as a result of COVID-19 vaccination in the WHO European Region, December 2020 to November 2021

50. Long-term health-related quality of life in non-hospitalised COVID-19 cases with confirmed SARS-CoV-2 infection in England: Longitudinal analysis and cross-sectional comparison with controls

Catalog

Books, media, physical & digital resources